A pharmacovigilance study to determine risk of mortality in male and female patients with Alzheimer's disease using Rivastigmine
This thesis is submitted in partial fulfillment of the requirements for the degree of Bachelor of Pharmacy, 2023.
Автор: | Shehab, Habibul Mohsin |
---|---|
Інші автори: | Yasmin, Hasina |
Формат: | Дисертація |
Мова: | English |
Опубліковано: |
Brac University
2024
|
Предмети: | |
Онлайн доступ: | http://hdl.handle.net/10361/22683 |
Схожі ресурси
-
Gender-specific Rhabdomyolysis risk in Alzheimer’s disease patients receiving memantine: a pharmacovigilance study
за авторством: Tabassum, Nadira
Опубліковано: (2024) -
Signal detection of rhabdomyolysis and death for rivastigmine: a pharmacovigilance study
за авторством: Mahee, Sadique Abdal
Опубліковано: (2024) -
Efficacy of Rivastigmine in Alzheimer’s disease- A structured seview
за авторством: Alim, Abdul
Опубліковано: (2023) -
Signal detection of Rhabdomyolysis and death for galantamine: a pharmacovigilance study
за авторством: Karmaker, Swastika
Опубліковано: (2024) -
A pharmacovigilance study on Donepezil: signal detection of rhabdomyolysis and death
за авторством: Jahan, Nusrat
Опубліковано: (2023)